Nearly one in three people with cystic fibrosis experienced nephrolithiasis during their lifetime. 2. The degree of exocrine pancreatic insufficiency control was not associated with nephrolithiasis. 3 ...

Dr. Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. The pancreas is an organ that makes enzymes for ...

Sjögren's disease, a heterogeneous autoimmune disorder characterized by exocrine glandular dysfunction, has a wide spectrum of manifestations. Clinical symptoms can be difficult to characterize, and ...

ABSTRACT: Background and Objectives: Metabolic syndrome (MetS), characterized by central obesity, hyperglycemia, dyslipidemia, and hypertension, is highly prevalent in populations with chronic ...

Exocrine tissues are classified by type of secretion, for example serous, mucous or mixed, and mechanism of release of secretory product e.g. merocrine, apocrine, holocrine. The salivary glands are ...

VIENNA, Austria — The appropriate dose of pancreatic enzyme replacement therapy (PERT) for exocrine pancreatic insufficiency (EPI) depends on the root cause of the insufficiency, according to results ...

Pancreatic elastase is the digestive enzyme the pancreas produces to help digest food. Doctors can measure elastase levels by testing a stool sample. Low levels could indicate exocrine pancreatic ...

Pancreatic insufficiency is typically a secondary cause as the result of a particular disease such as: chronic pancreatitis, acute pancreatitis, cystic fibrosis (CF), and pancreatic cancer. It can ...

Excessive intrapancreatic fat deposition (IPFD) leading to fatty change of the pancreas (FP) was prevalent in almost 18% of participants in a large population-based cohort, and both IPFD and FP were ...

Exocrine pancreatic insufficiency as a possible predictor of pancreatic cancer development. This is an ASCO Meeting Abstract from the 2024 ASCO Gastrointestinal Cancers Symposium. This abstract does ...

In a recent study published in the journal Signal Transduction and Targeted Therapy, researchers from Australia investigated the potential of small molecule inhibitors, specifically GSK126 (short for ...